Amwise Diagnostic

About:

Amwise Diagnostic is a leader in precision medicine technology for cancer.

Website: https://www.amwisediagnostics.com/

Top Investors: WI Harper Group, Simcere Pharma, Alibaba Entrepreneurs Fund, Lippo Group

Description:

Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Taipei, T'ai-pei, Taiwan

Founded Date:

2015-01-01

Contact Email:

service(AT)amwisediagnostics.com

Founders:

Xianlin Huang

Number of Employees:

11-50

Last Funding Date:

2020-02-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai